Iowa City, United States
iotaMotion, based in the United States, is a pioneering player in the convergence of the Biotechnology, Medical Devices, and Robotics industries. Established in 2015 by surgeons from the University of Iowa, it has been making significant strides in enhancing cochlear implant surgery.
The company's tagline, "Advancing Cochlear Implant Surgery Beyond Human Capability," encapsulates its mission to innovate in surgical technology. Its flagship product, the iotaSOFT Insertion System, exemplifies this by employing advanced robotics to slow the insertion of the cochlear implant electrode array to 0.1 mm/s, thereby minimizing force variations and enhancing patient outcomes.
iotaMotion recently secured a Series B funding round on 28 January 2025, underscoring its potential for growth in a competitive sector. With its innovative solutions, the company is poised to redefine cochlear implant procedures, offering a compelling opportunity for investors focusing on medical advancements.
